eprintid: 10144637
rev_number: 20
eprint_status: archive
userid: 699
dir: disk0/10/14/46/37
datestamp: 2022-03-04 11:04:52
lastmod: 2023-03-20 15:22:30
status_changed: 2022-03-04 11:04:52
type: article
metadata_visibility: show
sword_depositor: 699
creators_name: CRyPTIC Consortium, .
creators_name: Walker, Ann Sarah
title: Epidemiological cutoff values for a 96-well broth microdilution plate for high-throughput research antibiotic susceptibility testing of M. tuberculosis
ispublished: pub
divisions: UCL
divisions: J38
divisions: D65
divisions: B02
note: This version is the author accepted manuscript. For information on re-use, please refer to the publisher's terms and conditions.
abstract: Drug susceptibility testing of M. tuberculosis is rooted in a binary susceptible/resistant paradigm. Whilst there are considerable advantages in measuring the minimum inhibitory concentrations (MICs) of a panel of drugs for an isolate it is necessary to measure the epidemiological cutoff values (ECOFF/ECVs) to permit comparison with qualitative data. Here we present ECOFF/ECVs for 13 anti-TB compounds, including bedaquiline and delamanid, derived from 20 637 clinical isolates collected by 14 laboratories based in 11 countries on five continents. Each isolate was incubated for 14 days on a dry 96-well broth microdilution plate and then read. Resistance to most of the drugs due to prior exposure is expected and the MIC distributions for many of the compounds are complex and therefore a phenotypically wild-type population could not be defined. Since a majority of samples also underwent genetic sequencing, we defined a genotypically wild-type population and measured the MIC of the 99th percentile by direct measurement and via fitting a Gaussian using interval regression. The proposed ECOFF/ECV values were then validated by comparing to the MIC distributions of high-confidence genetic variants that confer resistance and to qualitative drug susceptibility tests obtained via Mycobacterial Growth Indicator Tube and the Microscopic-Observation Drug-Susceptibility assay. These ECOFF/ECV values will inform and encourage the more widespread adoption of broth microdilution – this is a cheap culture-based method that tests the susceptibility of 12–14 antibiotics on a single 96-well plate and so could help personalise the treatment of tuberculosis.
date: 2022-10-01
date_type: published
publisher: European Respiratory Society
official_url: https://doi.org/10.1183/13993003.00239-2022
oa_status: green
full_text_type: other
language: eng
primo: open
primo_central: open_green
verified: verified_manual
elements_id: 1942927
doi: 10.1183/13993003.00239-2022
lyricists_name: Walker, Ann
lyricists_id: ASWAL40
actors_name: Walker, Ann
actors_id: ASWAL40
actors_role: owner
full_text_status: public
publication: European Respiratory Journal
volume: 60
number: 4
article_number: 2200239
issn: 0903-1936
citation:        CRyPTIC Consortium, .;    Walker, Ann Sarah;      (2022)    Epidemiological cutoff values for a 96-well broth microdilution plate for high-throughput research antibiotic susceptibility testing of M. tuberculosis.                   European Respiratory Journal , 60  (4)    , Article 2200239.  10.1183/13993003.00239-2022 <https://doi.org/10.1183/13993003.00239-2022>.       Green open access   
 
document_url: https://discovery.ucl.ac.uk/id/eprint/10144637/2/Walker_Epidemiological%20cutoff%20values%20for%20a%2096-well%20broth%20microdilution%20plate%20for%20high-throughput%20research%20antibiotic%20susceptibility%20testing%20of%20M.%20tuberculosis_AAM.pdf
document_url: https://discovery.ucl.ac.uk/id/eprint/10144637/4/Walker_Epidemiological%20cutoff%20values%20for%20a%2096-well%20broth%20microdilution%20plate%20for%20high-throughput%20research%20antibiotic%20susceptibility%20testing%20of%20M.%20tuberculosis_SuppM.pdf
document_url: https://discovery.ucl.ac.uk/id/eprint/10144637/5/Walker_Epidemiological%20cutoff%20values%20for%20a%2096-well%20broth%20microdilution%20plate%20for%20high-throughput%20research%20antibiotic%20susceptibility%20testing%20of%20M.%20tuberculosis_SuppM2.tsv